Wells Fargo’s Alterity Therapeutics ATHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$365 Buy
+100
New +$453 ﹤0.01% 6570
2021
Q4
– Sell
-250
Closed -$3K – 7195
2021
Q3
$3K Hold
250
– – ﹤0.01% 6478
2021
Q2
$3K Hold
250
– – ﹤0.01% 6440
2021
Q1
$4K Hold
250
– – ﹤0.01% 6529
2020
Q4
$3K Hold
250
– – ﹤0.01% 6221
2020
Q3
$5K Hold
250
– – ﹤0.01% 6011
2020
Q2
$3K Hold
250
– – ﹤0.01% 6047
2020
Q1
$2K Hold
250
– – ﹤0.01% 5984
2019
Q4
$2K Buy
250
+242
+3,025% +$2.44K ﹤0.01% 6151
2019
Q3
$0 Sell
8
-42
-84% -$466 ﹤0.01% 6361
2019
Q2
$1K Buy
+50
New +$798 ﹤0.01% 6228
2018
Q2
– Sell
-83
Closed -$2K – 6309
2018
Q1
$2K Hold
83
– – ﹤0.01% 6181
2017
Q4
$3K Hold
83
– – ﹤0.01% 6124
2017
Q3
$2K Hold
83
– – ﹤0.01% 6138
2017
Q2
$2K Hold
83
– – ﹤0.01% 6035
2017
Q1
$3K Hold
83
– – ﹤0.01% 6105
2016
Q4
$1K Sell
83
-75
-47% -$2K ﹤0.01% 6141
2016
Q3
$7K Hold
158
– – ﹤0.01% 5832
2016
Q2
$8K Hold
158
– – ﹤0.01% 5719
2016
Q1
$4K Sell
158
-42
-21% -$1.4K ﹤0.01% 5895
2015
Q4
$9K Hold
200
– – ﹤0.01% 5752
2015
Q3
$11K Buy
200
+25
+14% +$1.58K ﹤0.01% 5701
2015
Q2
$12K Hold
175
– – ﹤0.01% 5746
2015
Q1
$12K Hold
175
– – ﹤0.01% 5559
2014
Q4
$18K Buy
175
+75
+75% +$8.11K ﹤0.01% 5398
2014
Q3
$13K Hold
100
– – ﹤0.01% 5473
2014
Q2
$13K Sell
100
-17
-15% -$1.94K ﹤0.01% 5538
2014
Q1
$20K Buy
117
+34
+41% +$18.8K ﹤0.01% 5223
2013
Q4
$35K Hold
83
– – ﹤0.01% 4841
2013
Q3
$21K Hold
83
– – ﹤0.01% 4940
2013
Q2
$12K Buy
+83
New +$11.3K ﹤0.01% 5008

Other funds holding ATHE

Wells Fargo's ATHE Position: Q3 2026 in Review

Wells Fargo opened a new position in Alterity Therapeutics (ATHE) in Q3 2026: 100 shares worth $365. The stake represents ﹤0.01% of the portfolio and ranks #6570 among its holdings. This is a return to the name: Wells Fargo previously reported a position in ATHE as recently as Q3 2021.

Wells Fargo first reported a position in ATHE in Q2 2013 and has held it in 31 quarters since. The position peaked at $35K in Q4 2013. 22 funds tracked by Wall St. Rank hold ATHE as of Q3 2026.

  • Wells Fargo held 100 shares of Alterity Therapeutics worth $365 as of Q3 2026.
  • Alterity Therapeutics was a new Wells Fargo position in Q3 2026.
  • Alterity Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #6570 holding.
  • Wells Fargo first reported a position in Alterity Therapeutics in Q2 2013 and has held it in 31 quarters since.
  • Wells Fargo's Alterity Therapeutics position peaked at $35K in Q4 2013.
  • 22 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q3 2026.

Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.